Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study.


Journal

Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637

Informations de publication

Date de publication:
27 09 2023
Historique:
received: 03 03 2023
accepted: 05 09 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

Patients with type 2 diabetes have an increased risk of death and cardiovascular events and people with diabetes or prediabetes have been found to have increased atherosclerotic burden in the coronary and carotid arteries. This study will estimate the cross-sectional prevalence of atherosclerosis in the coronary and carotid arteries in individuals with prediabetes and diabetes, compared with normoglycaemic individuals in a large population-based cohort. The 30,154 study participants, 50-64 years, were categorized according to their fasting glycaemic status or self-reported data as normoglycaemic, prediabetes, and previously undetected or known diabetes. Prevalence of affected coronary artery segments, severity of stenosis and coronary artery calcium score (CACS) were determined by coronary computed tomography angiography. Total atherosclerotic burden was assessed in the 11 clinically most relevant segments using the Segment Involvement Score and as the presence of any coronary atherosclerosis. The presence of atherosclerotic plaque in the carotid arteries was determined by ultrasound examination. Study participants with prediabetes (n = 4804, 16.0%) or diabetes (n = 2282, 7.6%) had greater coronary artery plaque burden, more coronary stenosis and higher CACS than normoglycaemic participants (all, p < 0.01). Among male participants with diabetes 35.3% had CACS ≥ 100 compared to 16.1% among normoglycaemic participants. For women, the corresponding figures were 8.9% vs 6.1%. The prevalence of atherosclerosis in the coronary arteries was higher in participants with previously undetected diabetes than prediabetes, but lower than in patients with known diabetes. The prevalence of any plaque in the carotid arteries was higher in participants with prediabetes or diabetes than in normoglycaemic participants. In this large population-based cohort of currently asymptomatic people, the atherosclerotic burden in the coronary and carotid arteries increased with increasing degree of dysglycaemia. The finding that the atherosclerotic burden in the coronary arteries in the undetected diabetes category was midway between the prediabetes category and patients with known diabetes may have implications for screening strategies and tailored prevention interventions for people with dysglycaemia in the future.

Sections du résumé

BACKGROUND
Patients with type 2 diabetes have an increased risk of death and cardiovascular events and people with diabetes or prediabetes have been found to have increased atherosclerotic burden in the coronary and carotid arteries. This study will estimate the cross-sectional prevalence of atherosclerosis in the coronary and carotid arteries in individuals with prediabetes and diabetes, compared with normoglycaemic individuals in a large population-based cohort.
METHODS
The 30,154 study participants, 50-64 years, were categorized according to their fasting glycaemic status or self-reported data as normoglycaemic, prediabetes, and previously undetected or known diabetes. Prevalence of affected coronary artery segments, severity of stenosis and coronary artery calcium score (CACS) were determined by coronary computed tomography angiography. Total atherosclerotic burden was assessed in the 11 clinically most relevant segments using the Segment Involvement Score and as the presence of any coronary atherosclerosis. The presence of atherosclerotic plaque in the carotid arteries was determined by ultrasound examination.
RESULTS
Study participants with prediabetes (n = 4804, 16.0%) or diabetes (n = 2282, 7.6%) had greater coronary artery plaque burden, more coronary stenosis and higher CACS than normoglycaemic participants (all, p < 0.01). Among male participants with diabetes 35.3% had CACS ≥ 100 compared to 16.1% among normoglycaemic participants. For women, the corresponding figures were 8.9% vs 6.1%. The prevalence of atherosclerosis in the coronary arteries was higher in participants with previously undetected diabetes than prediabetes, but lower than in patients with known diabetes. The prevalence of any plaque in the carotid arteries was higher in participants with prediabetes or diabetes than in normoglycaemic participants.
CONCLUSIONS
In this large population-based cohort of currently asymptomatic people, the atherosclerotic burden in the coronary and carotid arteries increased with increasing degree of dysglycaemia. The finding that the atherosclerotic burden in the coronary arteries in the undetected diabetes category was midway between the prediabetes category and patients with known diabetes may have implications for screening strategies and tailored prevention interventions for people with dysglycaemia in the future.

Identifiants

pubmed: 37759237
doi: 10.1186/s12933-023-01982-6
pii: 10.1186/s12933-023-01982-6
pmc: PMC10537533
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

261

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407–18.
doi: 10.1056/NEJMoa1608664 pubmed: 28402770
Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324):2140–4.
doi: 10.1016/S0140-6736(02)09089-X pubmed: 12090978
Player MS, Diaz VA, Mainous AG 3rd, Gregorie SH, Knoll ME, Everett CJ. Ethnic differences in the relationship of prediabetes with the presence of target-organ disease. Diabetes Metab. 2011;37(5):403–9. https://doi.org/10.1016/j.diabet.2010.12.009 .
doi: 10.1016/j.diabet.2010.12.009 pubmed: 21459647
Xing FY, Neeland IJ, Gore MO, Ayers CR, Paixao AR, Turer AT, Berry JD, Khera A, de Lemos JA, McGuire DK. Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the dallas heart study. Diab Vasc Dis Res. 2014;11(1):11–8. https://doi.org/10.1177/1479164113514239.PMID:24344119;PMCID:PMC5728654 .
doi: 10.1177/1479164113514239.PMID:24344119;PMCID:PMC5728654 pubmed: 24344119
Moebus S, Stang A, Möhlenkamp S, Dragano N, Schmermund A, Slomiany U, Hoffmann B, Bauer M, Broecker-Preuss M, Mann K, Siegrist J, Erbel R, Jöckel KH. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort–results of the Heinz Nixdorf recall study. Diabetologia. 2009;52(1):81–9. https://doi.org/10.1007/s00125-008-1173-y .
doi: 10.1007/s00125-008-1173-y pubmed: 18979083
Faeh D, William J, Yerly P, Paccaud F, Bovet P. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc Diabetol. 2007;24(6):32. https://doi.org/10.1186/1475-2840-6-32.PMID:17958881;PMCID:PMC2148037 .
doi: 10.1186/1475-2840-6-32.PMID:17958881;PMCID:PMC2148037
Scicali R, Giral P, Gallo A, Di Pino A, Rabuazzo AM, Purrello F, Cluzel P, Redheuil A, Bruckert E, Rosenbaum D. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients. Atherosclerosis. 2016;255:102–8. https://doi.org/10.1016/j.atherosclerosis.2016.11.003 .
doi: 10.1016/j.atherosclerosis.2016.11.003 pubmed: 27870948
Taron J, Lee S, Aluru J, Hoffmann U, Lu MT. A review of serial coronary computed tomography angiography (CTA) to assess plaque progression and therapeutic effect of anti-atherosclerotic drugs. Int J Cardiovasc Imaging. 2020;36:2305–17. https://doi.org/10.1007/s10554-020-01793-w .
doi: 10.1007/s10554-020-01793-w pubmed: 32076919 pmcid: 7434668
Maurovich-Horvat P, Ferencik M, Voros S, Merkely B, Hoffmann U. Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol. 2014;11:390–402. https://doi.org/10.1038/nrcardio.2014.60 .
doi: 10.1038/nrcardio.2014.60 pubmed: 24755916
Bergström G, Persson M, Adiels M, Björnson E, Bonander C, Ahlström H, Alfredsson J, Angerås O, Berglund G, Blomberg A, Brandberg J, Börjesson M, Cederlund K, de Faire U, Duvernoy O, Ekblom Ö, Engström G, Engvall JE, Fagman E, Eriksson M, Erlinge D, Fagerberg B, Flinck A, Gonçalves I, Hagström E, Hjelmgren O, Lind L, Lindberg E, Lindqvist P, Ljungberg J, Magnusson M, Mannila M, Markstad H, Mohammad MA, Nystrom FH, Ostenfeld E, Persson A, Rosengren A, Sandström A, Själander A, Sköld MC, Sundström J, Swahn E, Söderberg S, Torén K, Östgren CJ, Jernberg T. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144(12):916–29. https://doi.org/10.1161/CIRCULATIONAHA.121.055340 .
doi: 10.1161/CIRCULATIONAHA.121.055340 pubmed: 34543072 pmcid: 8448414
Bergström G, Berglund G, Blomberg A, Brandberg J, Engström G, Engvall J, Eriksson M, de Faire U, Flinck A, Hansson MG, Hedblad B, Hjelmgren O, Janson C, Jernberg T, Johnsson Å, Johansson L, Lind L, Löfdahl CG, Melander O, Östgren CJ, Persson A, Persson M, Sandström A, Schmidt C, Söderberg S, Sundström J, Toren K, Waldenström A, Wedel H, Vikgren J, Fagerberg B, Rosengren A. The Swedish CArdioPulmonary bioimage study: objectives and design. J Intern Med. 2015;278(6):645–59.
doi: 10.1111/joim.12384 pubmed: 26096600 pmcid: 4744991
National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. Type 2 diabetes: prevention in people at high risk (nice.org.uk) [Accessed 5 Apr 2022].
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. https://doi.org/10.1093/eurheartj/ehz486 .
doi: 10.1093/eurheartj/ehz486 pubmed: 31497854
Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, Cheng V, DeFrance T, Hellinger JC, Karlsberg RP. Society of cardiovascular computed tomography. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009;3(2):122–36. https://doi.org/10.1016/j.jcct.2009.01.001 .
doi: 10.1016/j.jcct.2009.01.001 pubmed: 19272853
Ayoub C, Erthal F, Abdelsalam MA, Murad MH, Wang Z, Erwin PJ, et al. Prognostic value of segment involvement score compared to other measures of coronary atherosclerosis by computed tomography: a systematic review and meta-analysis. J Cardiovasc Comput Tomogr. 2017;11(4):258–67.
doi: 10.1016/j.jcct.2017.05.001 pubmed: 28483581
Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004–2006–2011). Cerebrovasc Dis. 2012;34(4):290–6.
doi: 10.1159/000343145 pubmed: 23128470
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B. 1995;57(1):289–300.
Hanssen NM, Huijberts MS, Schalkwijk CG, Nijpels G, Dekker JM, Stehouwer CD. Associations between the ankle-brachial index and cardiovascular and all-cause mortality are similar in individuals without and with type 2 diabetes: nineteen-year follow-up of a population-based cohort study. Diabetes Care. 2012;35(8):1731–5. https://doi.org/10.2337/dc12-0178 .
doi: 10.2337/dc12-0178 pubmed: 22699294 pmcid: 3402264
Welsh C, Welsh P, Celis-Morales CA, Mark PB, Mackay D, Ghouri N, Ho FK, Ferguson LD, Brown R, Lewsey J, Cleland JG, Gray SR, Lyall DM, Anderson JJ, Jhund PS, Pell JP, McGuire DK, Gill JMR, Sattar N. Glycated hemoglobin, prediabetes, and the links to cardiovascular disease: data from UK Biobank. Diabetes Care. 2020;43(2):440–5. https://doi.org/10.2337/dc19-1683 .
doi: 10.2337/dc19-1683 pubmed: 31852727
Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, Yang Y, Hu Y, Huang Y. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:2297. https://doi.org/10.1136/bmj.m2297 .
doi: 10.1136/bmj.m2297
Elias-Smale SE, Proença RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, Steyerberg EW, Hofman A, Oudkerk M, Witteman JC. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the rotterdam study. J Am Coll Cardiol. 2010;56:1407–14. https://doi.org/10.1016/j.jacc.2010.06.029 .
doi: 10.1016/j.jacc.2010.06.029 pubmed: 20946998
Detrano R, Peterson D, Guerci A, Liu K, Shahar E, Ouyang P, Jackson S, Saad MF. Ethnic differences in coronary calcification: the multi-ethnic study of atherosclerosis (MESA). Circulation. 2005;111:1313–20. https://doi.org/10.1161/01.CIR.0000157730.94423.4B .
doi: 10.1161/01.CIR.0000157730.94423.4B pubmed: 15769774
Dragano N, Verde PE, Moebus S, Stang A, Schmermund A, Roggenbuck U, Möhlenkamp S, Peter R, Jöckel KH, Erbel R, Siegrist J. Subclinical coronary atherosclerosis is more pronounced in men and women with lower socio-economic status: associations in a population-based study. Coronary atherosclerosis and social status. Eur J Cardiovasc Prev Rehabil. 2007;14(4):568–74. https://doi.org/10.1097/HJR.0b013e32804955c4 .
doi: 10.1097/HJR.0b013e32804955c4 pubmed: 17667649
Schmermund A, Lehmann N, Bielak LF, Yu P, Sheedy PF II, Cassidy-Bushrow AE, Turner ST, Moebus S, Möhlenkamp S, Stang A, et al. Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America. Atherosclerosis. 2007;195:e207–16. https://doi.org/10.1016/j.atherosclerosis.2007.04.009 .
doi: 10.1016/j.atherosclerosis.2007.04.009 pubmed: 17532322 pmcid: 2293130
Rutter MK, Massaro JM, Hoffmann U, O’Donnell CJ, Fox CS. Fasting glucose, obesity, and coronary artery calcification in community-based people without diabetes. Diabetes Care. 2012;35(9):1944–50. https://doi.org/10.2337/dc11-1950 .
doi: 10.2337/dc11-1950 pubmed: 22773705 pmcid: 3425010
Rana JS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Cury R, Delago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann P, Karlsberg RP, Kim YJ, Leipsic J, Labounty TM, Lin FY, Maffei E, Raff G, Villines TC, Shaw LJ, Berman DS, Min JK. Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes): an international multicenter registry. Diabetes Care. 2012;35(8):1787–94. https://doi.org/10.2337/dc11-2403 .
doi: 10.2337/dc11-2403 pubmed: 22699296 pmcid: 3402246
Lim S, Choi SH, Choi EK, Chang SA, Ku YH, Chun EJ, Choi SI, Jang HC, Chang HJ. Comprehensive evaluation of coronary arteries by multidetector-row cardiac computed tomography according to the glucose level of asymptomatic individuals. Atherosclerosis. 2009;205(1):156–62. https://doi.org/10.1016/j.atherosclerosis.2008.10.041 .
doi: 10.1016/j.atherosclerosis.2008.10.041 pubmed: 19095235
Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35. https://doi.org/10.1056/NEJMoa1002358 .
doi: 10.1056/NEJMoa1002358 pubmed: 21247313
Reynolds HR, Shaw LJ, Min JK, Page CB, Berman DS, Chaitman BR, Picard MH, Kwong RY, O’Brien SM, Huang Z, Mark DB, Nath RK, Dwivedi SK, Smanio PEP, Stone PH, Held C, Keltai M, Bangalore S, Newman JD, Spertus JA, Stone GW, Maron DJ, Hochman JS. Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity. Circulation. 2021;144(13):1024–38. https://doi.org/10.1161/CIRCULATIONAHA.120.049755 .
doi: 10.1161/CIRCULATIONAHA.120.049755 pubmed: 34496632 pmcid: 8478888
Malik S, Budoff MJ, Katz R, Blumenthal RS, Bertoni AG, Nasir K, Szklo M, Barr RG, Wong ND. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care. 2011;34(10):2285–90. https://doi.org/10.2337/dc11-0816 .
doi: 10.2337/dc11-0816 pubmed: 21844289 pmcid: 3177707
Blanke P, Naoum C, Ahmadi A, Cheruvu C, Soon J, Arepalli C, Gransar H, Achenbach S, Berman DS, Budoff MJ, Callister TQ, Al-Mallah MH, Cademartiri F, Chinnaiyan K, Rubinshtein R, Marquez H, DeLago A, Villines TC, Hadamitzky M, Hausleiter J, Shaw LJ, Kaufmann PA, Cury RC, Feuchtner G, Kim YJ, Maffei E, Raff G, Pontone G, Andreini D, Chang HJ, Chow BW, Min J, Leipsic J. Long-term prognostic utility of coronary CT angiography in stable patients with diabetes mellitus. JACC Cardiovasc Imaging. 2016;9(11):1280–8. https://doi.org/10.1016/j.jcmg.2015.12.027 .
doi: 10.1016/j.jcmg.2015.12.027 pubmed: 27568114
Romanens M, Mortensen MB, Sudano I, Szucs T, Adams A. Extensive carotid atherosclerosis and the diagnostic accuracy of coronary risk calculators. Prev Med Rep. 2017;6:182–186. https://doi.org/10.1016/j.pmedr.2017.03.006 .
doi: 10.1016/j.pmedr.2017.03.006 pubmed: 28352516 pmcid: 5367800
Björk J, Strömberg U, Rosengren A, et al. Predicting participation in the population-based Swedish cardiopulmonary bio-image study (SCAPIS) using register data. Scand J Public Health. 2017;45(17 suppl):45–9.
doi: 10.1177/1403494817702326 pubmed: 28683666
Djekic D, Angerås O, Lappas G, et al. Impact of socioeconomic status on coronary artery calcification. Eur J Prev Cardiol. 2018;25(16):1756–64.
doi: 10.1177/2047487318792103 pubmed: 30095278
Shahim B, De Bacquer D, De Backer G, Gyberg V, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L. The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary artery disease: a report from EUROASPIRE IV: a survey from the European society of cardiology. Diabetes Care. 2017;40(9):1233–40. https://doi.org/10.2337/dc17-0245 .
doi: 10.2337/dc17-0245 pubmed: 28637653 pmcid: 5566283

Auteurs

Carl Johan Östgren (CJ)

Department of Health, Medicine and Caring Sciences, Centre of Medical Image Science and Visualization (CMIV), Linköping University, 581 83, Linköping, SE, Sweden. carl.johan.ostgren@liu.se.
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. carl.johan.ostgren@liu.se.

Julia Otten (J)

Department of Public Health and Clinical Medicine, Section of Medicine, Umeå University, Umeå, Sweden.

Karin Festin (K)

Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Oskar Angerås (O)

Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Göran Bergström (G)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Kerstin Cederlund (K)

Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.

Gunnar Engström (G)

Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.

Maria J Eriksson (MJ)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden.

Mats Eriksson (M)

Medicine Unit Endocrinology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.
Unit of Endocrinology, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden.

Tove Fall (T)

Department of Medical Sciences, Molecular Epidemiology, Uppsala University, Uppsala, Sweden.

Anders Gummesson (A)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.

Emil Hagström (E)

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Urban Hellman (U)

Department of Public Health and Clinical Medicine, Section of Medicine, Umeå University, Umeå, Sweden.

Stefan K James (SK)

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Tomas Jernberg (T)

Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institute, Stockholm, Sweden.

Johan Kihlberg (J)

Department of Health, Medicine and Caring Sciences, Centre of Medical Image Science and Visualization (CMIV), Linköping University, 581 83, Linköping, SE, Sweden.
Department of Radiology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

David Kylhammar (D)

Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences and Department of Clinical Physiology, Linköping University, Linköping, Sweden.

Hanna Markstad (H)

Center for Medical Imaging and Physiology, Skåne University Hospital and Lund University, Lund, Sweden.
Experimental Cardiovascular Research, Clinical Research Center, Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Peter Nilsson (P)

Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.

Anders Persson (A)

Department of Health, Medicine and Caring Sciences, Centre of Medical Image Science and Visualization (CMIV), Linköping University, 581 83, Linköping, SE, Sweden.
Department of Radiology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Department of Clinical Sciences, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.

Margaretha Persson (M)

Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.

Carlo Pirazzi (C)

Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Rebecka Renklint (R)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Annika Rosengren (A)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital Östra Hospital, Gothenburg, Sweden.

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, Section of Medicine, Umeå University, Umeå, Sweden.

Johan Sundström (J)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH